<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03736226</url>
  </required_header>
  <id_info>
    <org_study_id>S2424</org_study_id>
    <nct_id>NCT03736226</nct_id>
  </id_info>
  <brief_title>A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China</brief_title>
  <official_title>A Post-Approval, Single-Arm Study of the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, observational, single-arm, open-label, multicenter, post-approval study. To&#xD;
      compile real-world clinical outcomes data for the SYNERGYTM MONORAILTM Everolimus-Eluting&#xD;
      Platinum Chromium Coronary Stent System (SYNERGYTM Stent System) in real-world clinical&#xD;
      practice in China.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective, open-label, multi-center study is designed to provide post-market&#xD;
      surveillance information on the SYNERGY Stent System. The study will evaluate clinical&#xD;
      outcomes of subjects receiving the SYNERGY™ stents over 5 years in a real world setting&#xD;
      according to post approval requirements by China government.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>MACE rate</measure>
    <time_frame>12 months</time_frame>
    <description>endpoints will be assessed post stent implant</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SYNERGYTM Stent System</intervention_name>
    <description>no intervention design in the study</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        &quot;all comers&quot; study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Subject must be at least 18 years of age&#xD;
&#xD;
               -  Subject understands and provides written informed consent&#xD;
&#xD;
               -  Subject who is clinically indicated and will have an attempt of at least one&#xD;
                  SYNERGYTM stent OR Subject who is clinically indicated and was implanted with at&#xD;
                  least one SYNERGYTM stent&#xD;
&#xD;
               -  Subject is willing to comply with all protocol-required follow-up evaluation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion criteria are not required in this study which is an &quot;all comers&quot; study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhiyu Zeng</last_name>
    <role>Study Chair</role>
    <affiliation>Boston Scientific Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuwei ZHANG</last_name>
    <phone>+86 10 85216440</phone>
    <email>zhany18@bsci.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Hospital Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JUNBO GE</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 30, 2018</study_first_submitted>
  <study_first_submitted_qc>November 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

